EUVIMEDEUVIMED entdecken
Open Access

Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Diabetic β-Cell Apoptosis and Dedifferentiation by Delivering miR-4436

Jianbo Xu, Yuntong Sun, Fengtian Sun

Tissue Engineering and Regenerative Medicine · 2026-08 · 23 (6) · 901-915

DOI: 10.1007/s13770-026-00823-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tissue Engineering and Regenerative Medicine, online erschienen am 27.06.2026. Verfasst von Jianbo Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, Zhejiang, China. Hauptthemen laut MEDLINE: MicroRNAs, Apoptosis, Extracellular Vesicles, Mesenchymal Stem Cells. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Jinhua Science and Technology Research Program, Zhejiang Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by β-cell dysfunction and insulin resistance with limited treatment options. The targeting of pancreatic β-cell apoptosis and dedifferentiation represents a promising approach for T2DM therapy. Recently, mesenchymal stem cell-derived extracellular vesicles (MSC-EVs) have demonstrated repair potential for metabolic diseases. However, the effects of MSC-EVs on β-cell apoptosis and dedifferentiation in T2DM remain largely unclear. METHODS: We established db/db mouse model and high glucose-stimulated MIN6 cell model to evaluate the therapeutic efficacy of MSC-EVs in vivo and in vitro. Transcriptome sequencing, proteomic analysis, and microRNA (miRNA) sequencing were applied to explore the molecular mechanism underlying MSC-EV-induced β-cell protection. RESULTS: MSC-EVs significantly mitigated hyperglycemia, improved glucose tolerance, and restored β-cell function by preventing β-cell loss and reducing dedifferentiated β-cell populations in db/db mice. Mechanistically, MSC-EV treatment reversed hyperglycemia-induced ecotropic virus integration site 1 (EVI1) upregulation in β cells, and EVI1 knockdown significantly suppressed β-cell apoptosis and dedifferentiation by promoting forkhead box protein O1 (FOXO1) expression. MiRNA sequencing revealed that miR-4436 enriched in MSC-EVs inhibited EVI1 expression by directly binding to EVI1 mRNA. MiR-4436 knockdown abolished the therapeutic effects of MSC-EVs in T2DM CONCLUSION: MSC-EVs inhibit pancreatic β-cell loss and dedifferentiation by miR-4436-mediated EVI1/FOXO1 regulation. Therefore, MSC-EV administration may represent a promising therapeutic strategy for T2DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsApoptosisExtracellular VesiclesMesenchymal Stem CellsInsulin-Secreting CellsCell DedifferentiationDiabetes Mellitus, Type 2Diabetes Mellitus, ExperimentalAnimalsMiceForkhead Box Protein O1MDS1 and EVI1 Complex Locus ProteinMaleMice, Inbred C57BL

Stichwörter der Autor:innen

Extracellular vesiclesMesenchymal stem cellsType 2 diabetes mellitus

Substanzen

MicroRNAsForkhead Box Protein O1MDS1 and EVI1 Complex Locus Protein

Autor:innen und Institutionen

  • Department of Anesthesiology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, Zhejiang, China.
  • Department of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, 365 Renmin East Road, Jinhua, 321000, Zhejiang, China. zjdxsyt@163.com.
  • Department of Clinical Laboratory, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, 365 Renmin East Road, Jinhua, 321000, Zhejiang, China. jsdxsft@163.com.

Förderung

  • National Natural Science Foundation of China
  • Jinhua Science and Technology Research Program
  • Zhejiang Provincial Natural Science Foundation of China

Zitieren

APA

Xu, J., Sun, Y., & Sun, F. (2026). Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Diabetic β-Cell Apoptosis and Dedifferentiation by Delivering miR-4436. Tissue Engineering and Regenerative Medicine, 23(6), 901-915. https://doi.org/10.1007/s13770-026-00823-3

Vancouver

Xu J, Sun Y, Sun F. Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Diabetic β-Cell Apoptosis and Dedifferentiation by Delivering miR-4436. Tissue Engineering and Regenerative Medicine. 2026;23(6):901-915. doi:10.1007/s13770-026-00823-3

BibTeX
@article{Xu2026,
  author = {Xu, Jianbo and Sun, Yuntong and Sun, Fengtian},
  title = {Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuate Diabetic β-Cell Apoptosis and Dedifferentiation by Delivering miR-4436},
  journal = {Tissue Engineering and Regenerative Medicine},
  year = {2026},
  volume = {23},
  number = {6},
  pages = {901--915},
  doi = {10.1007/s13770-026-00823-3}
}
Kostenlos starten →